Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

February 28, 2006

Conditions
Pancreatic Cancer
Interventions
DRUG

Rubitecan

Trial Locations (11)

11023

Cancer Research of Long Island, Great Neck

29403

Charleston Hematology Oncology, PA, Charleston

38801

N. Mississippi Hematology & Oncology Associates, Tupelo

40202

Norton Healthcare, Inc., Louisville

64111

Kansas City Cancer Center, Kansas City

70809

Mary Bird Perkins Cancer Center, Baton Rouge

Medical Oncology, Baton Rouge

80210

Mile High Oncology, Denver

92708

11100 Warner Avenue, Ste. 200, Fountain Valley

92882

Compassionate Cancer Care Medical Group, Corona

95073

The Cancer Research & Prevention Center, Soquel

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY